Search clinical trials for: GSK3739937 (Tablet)

Total 7366 results

Shandong First Medical University

Recruiting

Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

Chronic Coronary Syndrome

China
Shouyao Holdings (Beijing) Co. LTD

Recruiting

A Study of SY-5933 in Patients With Advanced Solid Tumors Harboring the KRAS p.G12C Mutation

Advanced Solid Tumor

China
Shouyao Holdings (Beijing) Co. LTD

Recruiting

A First-in-Human, Phase 1 Study of SY-4798 in Patients With Advanced Solid Tumor

Advanced Solid Tumor

China
Nationwide Children's Hospital
Children's Hospital Colorado

Recruiting

MEKTOVI® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Adamantinous Craniopharyngioma | Recurrent Adamantinomatous Craniopharyngioma

United States, United Kingdom, Australia, Canada, Germany, Netherlands
Daewoong Pharmaceutical Co. LTD.

Recruiting

Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics After Intravenous DWJ1521 Administration in Healthy Adult Volunteers

Healthy

Korea, Republic of
Charles A. Czeisler, PhD, MD
Axsome Therapeutics, Inc.

Recruiting

Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder

Excessive Sleepiness | Shift-work Disorder

United States
Hartford Hospital
Spero Therapeutics

Completed

Bioavailability of Tebipenem (SPR994) Crushed Tablet

Relative Bioavailability

United States
Yale University
National Institute on Drug Abuse (NIDA); Medical University of South Carolina; Johns Hopkins University and other collaborators

Completed

Fatty Acid Amide Hydrolase (FAAH) Inhibitor Treatment of Cannabis Use Disorder (CUD) (FAAH-I MULTI)

Cannabis Use Disorder

United States
Stony Brook University
Eisai Inc.

Terminated

A Clinical Trial to Evaluate the Safety and Efficacy of Fycompa in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis

United States
Helsinn Healthcare SA

Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer | Cachexia; Cancer

United States, Russian Federation, Bulgaria, Hungary, Italy, Romania, Serbia
Helsinn Healthcare SA

Completed

A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Non Small Cell Lung Cancer | Cachexia; Cancer

United States, Croatia, Australia, Belgium, Russian Federation, Poland, Romania, Ukraine
University of North Carolina, Chapel Hill

Completed

Patient Portal Use by Parents of Spanish-Speaking Children

Patient Engagement

United States
Sensorion

Completed

Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss (AUDIBLE-S)

Severe Sudden Sensorineural Hearing Loss

Israel, United Kingdom, France, Serbia, Bulgaria, Canada, Czechia, Germany, Slovakia, Turkey
University of California, San Francisco

Completed

Wayfinding Intervention in High-Fidelity Long-Term Memory (LABYR)

Mild Cognitive Impairment | Long-Term Memory Decline

United States
Odense University Hospital
Rigshospitalet, Denmark; Danish Cancer Society; REHPA, The Danish Knowledge Centre...

Completed

The Use of PatientReportedOutcomes (PRO)- CTCAE by Melanoma Patients Receiving Immunotherapy

Adverse Effects

Denmark
Virios Therapeutics, Inc.

Completed

Fibromyalgia Outcome Research Trial Evaluating Synergistic Suppression of HSV-1 (FORTRESS)

Fibromyalgia

United States
Dana-Farber Cancer Institute
Amgen

Terminated

Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy.

Lymphoma | Autonomic Imbalance | Cancer Survivorship

United States
LG Chem

Completed

Relative Bioavailability Study to Assess an LC350189 Tablet Compared to an LC350189 Capsule in Healthy Adults

Hyperuricemia | Gout

United States
Luye Pharma Group Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Ansofaxine Hydrochloride Extended-release Tablets in the Treatment of Major Depressive Disorder (MDD)

Major Depressive Disorder (MDD)

China
Astellas Pharma Global Development, Inc.

Completed

A Study to Assess the Relative Bioavailability of Gilteritinib Following a Single Dose of Gilteritinib Mini-tablet Oral Suspension and Gilteritinib Mini-tablets Compared to a Single Dose of Gilteritinib Tablet in Healthy Subjects

Healthy Volunteer

United States
Jazz Pharmaceuticals

Completed

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"

Narcolepsy

United States, France, Canada, Germany, Finland, Netherlands
Jazz Pharmaceuticals

Completed

"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA" (OSA)

Obstructive Sleep Apnea

United States, France, Canada, Germany, Netherlands
Eli Lilly and Company

Completed

A Study of Baricitinib in Healthy Participants

Healthy

Singapore
University Hospital, Grenoble

Unknown

Severe Chronic Respiratory Failure and Citrulline

Pulmonary Disease, Chronic Obstructive

France
Mission Pharmacal

Unknown

Phase II Proof of Concept Study in Uncomplicated UTI

Urinary Tract Infections

United States
ALK-Abelló A/S
Inflamax Research Incorporated

Completed

A Dose-response Evaluation of the SQ Tree SLIT-tablet Using an Environmental Exposure Chamber

Allergic Rhinoconjunctivitis

Canada
University Hospital, Geneva

Unknown

Tablet-guided Versus Freehand (Tab-Guide) Ventriculostomy : Study Protocol to the Test Accuracy of Ventriculostomy in a Randomized Controlled Trial (Tab-Guide)

Hydrocephalus.

Switzerland
Pfizer
Medivation, Inc.

Terminated

An Extension To The B1451006 Protocol To Evaluate The Safety and Efficacy of Dimebon In Subjects With Moderate-to-Severe Alzheimer's Disease

Alzheimer's Disease

United States
Jiangsu vcare pharmaceutical technology co., LTD

Recruiting

Efficacy and Safety Clinical Study of VC005 Tablets in Adult Patients With Moderate to Severe Atopic Dermatitis

Moderate to Severe Atopic Dermatitis

China
Shenzhen NewDEL Biotech, Co., Ltd
Shenzhen Innovation Center for Small Molecule Drug Discovery Co., Ltd.

Enrolling by invitation

An Open-label, Phase 1 Study to Determine the Maximum Tolerated Dose of ND-003 in Patients With Advanced Solid Cancers

Advanced Solid Tumor

China
Akros Pharma Inc.

Completed

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis (IMPACT-PS)

Skin Diseases | Psoriasis | Plaque Psoriasis

United States, Canada, Poland
Guang'anmen Hospital of China Academy of Chinese...

Unknown

Efficacy and Safety of Xueshuanxinmaining Tablet for the Treatment of Stable Angina Pectoris

Coronary Heart Disease | Stable Angina
Convalife (Shanghai) Co., Ltd.

Not yet recruiting

CVL237 Tablets for APDS/PASLI

PI3K and P110delta Hyperactivation Syndrome

China
Chengdu Suncadia Medicine Co., Ltd.

Active, not recruiting

A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs)

Chronic Hepatitis B

China
Jiangsu vcare pharmaceutical technology co., LTD

Completed

A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.

Rheumatoid Arthritis

China
University of Tartu

Completed

The Effect of Semaglutide on Pituitary Function

Healthy

Estonia
McNeil AB

Completed

A Comparison of Three Medications to Treat Diarrhea in Adults.

Diarrhea

India, Mexico
Boehringer Ingelheim

Completed

Bioavailability of a Fixed Dose Combination Tablet With Empagliflozin (BI 10773) and Metformin Compared With the Monocomponents and Effect of Food on Bioavailability

Diabetes Mellitus, Type 2

Germany
ShuGuang Hospital
Hubei Hospital of Traditional Chinese Medicine; Wuhan No.1 Hospital; Wuhan Third... and other collaborators

Completed

Treatment of Pulmonary Fibrosis Due to COVID-19 With Fuzheng Huayu

Pulmonary Fibrosis Due to COVID-19

China
AstraZeneca

Completed

A Study to Assess the Bioequivalence of R406 in Healthy Volunteers When Given 100mg and 150 mg of Fostamatinib (Fosta BE)

Healthy Volunteers

United States
BDH-Klinik Hessisch Oldendorf
Gottfried Wilhelm Leibniz Universität Hannover

Recruiting

Sensorimotor Arm Rehabilitation After Stroke (TAB-APP)

Stroke | Hemiparesis

Germany
Shanghai YingLi Pharmaceutical Co. Ltd.

Not yet recruiting

A Study of Linperlisib Combination With Camrelizumab in Patients With Solid Tumor

Advanced Solid Tumor
Indiana University
National Institute on Alcohol Abuse and Alcoholism (NIAAA); Cedars-Sinai Medical...

Recruiting

SAMe Trial for Patients With Alcoholic Cirrhosis

Alcoholic Cirrhosis

United States
University of Vermont
Duke University

Completed

MitoQ for the Treatment of Metabolic Dysfunction in Asthma (MIMDA)

Obesity | Asthma

United States
Simcere Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Pharmacokinetics,Safety and Tolerability of Y-2 Sublingual Tablet in Healthy Adult Subjects

Healthy

United States
Guangzhou Lupeng Pharmaceutical Company LTD.

Completed

A Food Effect Study of LP-168 Tablets in Healthy Subjects

Mantle Cell Lymphoma

China
Pipeline Therapeutics, Inc.

Completed

Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers

Multiple Sclerosis

Australia
Cerevel Therapeutics, LLC

Completed

An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects

Healthy Subjects

United States
Calo Psychiatric Center

Completed

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

Schizophrenia

Taiwan
Rhode Island Hospital
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

An Emotion Regulation Intervention for Early Adolescent Risk Prevention

Risk Behavior | Risk Reduction | Emotion Regulation

United States

Search clinical trials for: GSK3739937 (Tablet)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Malaysia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations